Westlake Chemical Partners (WLKP) Q4 2025 earnings review
Turnaround Complete, Coverage Ratio Rebounds
Westlake Chemical Partners successfully exited a challenging year dominated by the major Petro 1 facility turnaround. Q4 results show a return to structural stability, with Distributable Cash Flow (DCF) climbing to $18.8M—generating a robust 1.13x quarterly coverage ratio, the highest since Q4 2022. While full-year net income (-22% YoY) and operating cash flow (-42% YoY) look grim on paper, they are entirely reflective of the planned H1 downtime. With no turnarounds scheduled for 2026, the focus shifts back to the partnership's predictable fee-based cash flows and defending its 46-quarter streak of steady distributions.
🐂 Bull Case
The massive Petro 1 turnaround, which crushed Q1/Q2 cash flows and required heavy maintenance capex, is fully in the rearview. Q4 results confirm the facility is back to generating highly stable cash flows. No turnarounds are planned for 2026.
Despite a severe drop in coverage during the first half of the year, WLKP utilized its operating surplus to maintain its $0.4714 quarterly distribution, marking its 46th consecutive payout. The business model functioned exactly as designed during a stress period.
🐻 Bear Case
While Q4 coverage was 1.13x, the Trailing Twelve-Month (TTM) coverage ratio sits at just 0.80x. The partnership leaned on cash reserves to fund the payout in 2025, slightly depleting its balance sheet cushion.
While the Westlake contract (95% of volume) is insulated, the 5% sold to third parties suffered. Q4 third-party sales fell 12% YoY, indicating persistent macro weakness in the global chemical market.
⚖️ Verdict: 🟢
Bullish. The partnership endured its most capital-intensive operational hurdle (Petro 1 turnaround) without cutting its distribution. With the plant back online, capex normalizing, and a clear operational runway for 2026, the underlying fee-based yield is secure.
Key Themes
Capital Expenditure Normalization
A major driver of Q4's 1.13x coverage ratio was the normalization of maintenance capital expenditures. Spending was aggressively front-loaded into the first half of 2025 to support the Petro 1 turnaround. This timing shift freed up cash in Q4, driving DCF up 25% sequentially and providing a clear glimpse into the normalized cash generation profile for 2026.
The Fixed-Margin Shield Remains Intact
The Ethylene Sales Agreement (renewed through 2027) functioned perfectly as a downside shield. By selling 95% of OpCo's production to the parent at a fixed $0.10/lb margin (net of operating costs), the partnership sidestepped the commodity price volatility that typically plagues chemical producers. Westlake Corporation absorbed the market risk, leaving WLKP to simply focus on facility uptime.
Third-Party Segment Weakness Exposes Macro Risks
The 5% of production not shielded by the parent contract is sold to third parties. In Q4, third-party revenue declined 12.2% YoY to $26.2M, contrasting sharply with the 14.1% YoY growth in revenue from Westlake. Management previously cited soft global industrial and manufacturing activity. While small, this segment is the primary variable driver of margin upside, and it is currently dragging on profitability.
TTM Coverage Contradicts Q4 Strength
While management highlighted the 1.13x coverage ratio for Q4, the Trailing Twelve-Month (TTM) coverage ratio tells a sobering story: it sits at 0.80x. This means that for the full year 2025, the partnership effectively distributed more cash than it generated, pulling from historical reserves. The 1.1x long-term target will take multiple clean quarters to restore on a TTM basis.
Growth Levers Remain Frozen
Management has historically outlined four growth levers (increasing OpCo ownership, M&A, organic expansion, negotiating higher margins). However, with the parent C-Corp currently not requiring capital and the MLP equity market remaining tight, these growth avenues appear indefinitely stalled. WLKP is currently functioning strictly as an income vehicle with zero near-term distribution growth expected.
Petro 1 Reliability Validated Post-Turnaround
The successful restart of the Petro 1 facility (which operated for over 8 years prior to this turnaround) is a critical operational driver. Q4 production levels demonstrate the facility is running reliably at nameplate capacity. This operational stability underpins the entire 2026 cash flow thesis.
Other KPIs
Decelerating/Reversing. Down drastically (-42%) from $485.0M in FY24. This massive cash burn occurred in H1 2025 due to lost revenue and direct cash expenditures for the Petro 1 turnaround, underscoring the cyclical capital intensity of chemical infrastructure.
Decelerating. Down from $62.4M ($1.77/unit) in 2024. Despite a stable Q4 ($14.5M), the hole dug in Q1 ($4.9M) was too deep to overcome for the full fiscal year.
Guidance
Accelerating. With the Petro 1 turnaround complete and no other major maintenance outages planned for 2026, management expects a clean operational runway resulting in higher volumes.
Accelerating. Management explicitly guides for an improvement in the coverage ratio compared to 2025. Given that Q4 already hit 1.13x, the implied expectation is a return to the historical long-term target of ~1.1x on an annualized basis.
Key Questions
Third-Party Margin Outlook
With third-party revenues down 12% YoY in Q4 despite higher overall production volumes, what are your expectations for spot ethylene pricing and margins in the broader macroeconomic environment for 2026?
Pacing the TTM Coverage Recovery
Given the trailing twelve-month coverage ratio ended 2025 at 0.80x, by which quarter do you realistically expect the TTM metric to cross back above the 1.0x threshold?
Trigger for Growth Levers
You have consistently mentioned four growth levers but have cited the parent company's lack of capital needs as a reason to hold off. What specific market or internal triggers would prompt you to execute on a dropdown or increase the OpCo ownership stake?